Fermata Advisors, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
Fermata Advisors, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$383,888
+146.0%
56,702
+130.4%
0.11%
+134.8%
Q4 2022$156,035
+3.3%
24,611
+1.2%
0.05%
-6.1%
Q3 2022$151,000
-28.8%
24,311
+1.2%
0.05%
-33.8%
Q2 2022$212,000
+28.5%
24,011
+22.6%
0.07%
+19.4%
Q1 2022$165,000
-9.8%
19,586
+9.1%
0.06%
-7.5%
Q4 2021$183,000
-26.5%
17,955
+39.9%
0.07%
-39.1%
Q3 2021$249,000
+20.9%
12,830
+9.2%
0.11%
-8.3%
Q2 2021$206,00011,7500.12%
Other shareholders
INMUNE BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 178,284$1,219,4630.13%
Fermata Advisors, LLC 56,702$383,8880.11%
Westside Investment Management, Inc. 41,540$281,2270.08%
QUADRANT CAPITAL GROUP LLC 60,000$406,2000.04%
MAI Capital Management 97,410$659,4660.01%
Janney Montgomery Scott LLC 256,887$1,7390.01%
Financial Advocates Investment Management 11,510$78,3200.01%
VALLEY NATIONAL ADVISERS INC 1,000$70.00%
Beacon Pointe Advisors, LLC 10,368$70,1910.00%
Asset Dedication, LLC 814$60.00%
View complete list of INMUNE BIO INC shareholders